Type of Intervention: Specific Action
Sectors Involved: Health
Intervention Categories: Legal and policy; Regulatory change
Level of Jurisdiction: Ontario
Lead People/Agency: Deputy Premier, Minister of Health
Overview: The Ontario government is making the cost of prescription drugs more affordable during the COVID-19 pandemic. Effective May 13, those using the Ontario Drug Benefit Program will not be required to pay any co-payment until July 1, 2020 for any prescription of 30+ days. Additionally, existing and new Trillium Drug Program households can apply for income reassessment to help reduce financial burden.
Full details here: https://news.ontario.ca/mohltc/en/2020/05/ontario-making-prescription-drugs-more-affordable-during-covid-19.html
Type of Justification: Providing support
Evidence/Justification: The Ontario government justifies this action as a means to provide additional relief for vulnerable people impacted by COVID-19. This action will help ensure people continue to have access to their required prescription drugs, mitigating stress and financial burden. No evidence sources are cited.